Search

Your search keyword '"Can-Fite BioPharma Ltd."' showing total 72 results
Start Over Descriptor "Can-Fite BioPharma Ltd." Publisher plus media solutions
72 results on '"Can-Fite BioPharma Ltd."'

1. CN Joining The Commtrex Marketplace

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) is pleased to announce that it has joined The Commtrex Transload Marketplace, offering customers one-stop [...]

Published
2020

2. FDA Clears Can-Fite to Commence Phase II COVID-19 Study

Subjects
United States. Food and Drug Administration, Can-Fite BioPharma Ltd., Liver diseases -- Care and treatment, Medical research, Pharmaceutical industry, COVID-19 -- Care and treatment, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite BioPharma Ltd. has issued the following news release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address [...]

Published
2020

3. CN to participate in a virtual fireside chat with Scotiabank Research on September 2

Subjects
Can-Fite BioPharma Ltd., Vice presidents (Organizations), General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: JJ Ruest, President and Chief Executive Officer and Keith Reardon, Senior Vice-President, Consumer Product Supply Chain of CN (TSX: CNR) [...]

Published
2020

4. Can-Fite to Present at The LD Micro 500 Virtual Conference on September 1, 2020

Subjects
Can-Fite BioPharma Ltd., Conferences and conventions, Liver cancer, General interest, News, opinion and commentary
Abstract

LOS ANGELES: Can-Fite BioPharma has issued the following news release: Can-Fite BioPharma Ltd. (NYSE American:CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, [...]

Published
2020

7. CN Breaks Multiple Grain Records

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) announced today that it has achieved another monthly record in June moving 2.7 million metric [...]

Published
2020

8. Can-Fite Announces $3.4 Million Registered Direct Offering

Subjects
United States. Securities and Exchange Commission, Can-Fite BioPharma Ltd., Private placements (Securities), Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

PETACH TIKVA, Israel: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs [...]

Published
2020

9. News Flash:Can-Fite Announces $3.4 Million Registered Direct Offering

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

-Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced that it has [...]

Published
2020

10. CANF gains 6% in premarket

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

Can-Fite BioPharma Ltd. CANF 0.35% shares rose 6.2% to $1.89 in pre-market [...]

Published
2020

11. Can-Fite Announces $8.0 Million Registered Direct Offering

Subjects
United States. Securities and Exchange Commission, Can-Fite BioPharma Ltd., Private placements (Securities), Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

PETACH TIKVA: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that [...]

Published
2020

12. News Flash:Can-Fite Announces $8.0 Million Registered Direct Offering

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

-Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced that it has [...]

Published
2020

13. Can-Fite Participating in BIO Digital International Convention and One-on-One Partnering Meetings on June 8-12, 2020

Subjects
Can-Fite BioPharma Ltd., Conferences and conventions, Liver cancer, Biotechnology industries, Pharmaceutical industry, International cooperation, Vice presidents (Organizations), Liver diseases, Biological products industry, Partnerships, Liver, Diseases, General interest, News, opinion and commentary
Abstract

PETACH TIKVA, Israel: Can-Fite BioPharma Ltd has issued the following news release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs [...]

Published
2020

14. News Flash:Can-Fite Participating in BIO Digital International Convention and One-on-One Partnering Meetings on June 8-12, 2020

Subjects
Can-Fite BioPharma Ltd., Conferences and conventions, Biotechnology industries, Pharmaceutical industry, International cooperation, General interest, News, opinion and commentary
Abstract

-Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that the Company's [...]

Published
2020

15. Can-Fite BioPharma to Hold Investor Webinar and Q&A Session with CEO on June 4th

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Biological products industry, Chief executive officers, Liver diseases, Liver, Biotechnology industries, Diseases, General interest, News, opinion and commentary
Abstract

PETACH TIKVA: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs [...]

Published
2020

16. News Flash:LCan-Fite BioPharma to Hold Investor Webinar and Q&A Session with CEO on June 4th

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Biological products industry, Chief executive officers, Liver diseases, Liver, Biotechnology industries, Diseases, General interest, News, opinion and commentary
Abstract

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced CEO Dr. [...]

Published
2020

17. Can-Fite to Host First Quarter 2020 Financial Results & Clinical Update Conference Call on June 1, 2020

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Biological products industry, Finance, Biotechnology industries, Diseases, General interest, News, opinion and commentary
Abstract

PETACH TIKVA: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that [...]

Published
2020

18. Can-Fite Reports Additional Findings from Successful Phase II NASH Study: 25 mg Dose of Namodenoson Significantly Reduced Liver Fat and Fibrosis

Subjects
Can-Fite BioPharma Ltd., Liver diseases -- Research -- Care and treatment, Medical research, Pharmaceutical industry -- Research, Liver -- Research, Fatty liver, Cancer research, Fibrosis, Biological products industry, Biotechnology industries, Diseases, General interest, News, opinion and commentary
Abstract

PETACH TIKVA: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that [...]

Published
2020

19. Can-Fite: Piclidenoson is Submitted for Compassionate Use Treatment for Coronavirus Patients in Israel

Subjects
Can-Fite BioPharma Ltd., Medical centers, Liver cancer -- Care and treatment, Pharmaceutical industry, Liver diseases, Biological products industry, Liver, Diseases, General interest, News, opinion and commentary
Abstract

PETACH TIKVA, Israel: Can-Fite BioPharma Ltd. has issued the following news release: -Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs [...]

Published
2020

20. Can-Fite: New Pre-clinical Studies Demonstrate Inhibition of Fat Cell Expansion by Cannabis Derived CBD

Subjects
Can-Fite BioPharma Ltd., Clinical trials, Obesity, Marijuana, Medical research, Pharmaceutical industry, Liver diseases, Biological products industry, Liver, Biotechnology industries, Diseases, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite BioPharma Ltd. has issued the following news release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address [...]

Published
2020

21. CN recognized as one of Canada's Best Diversity Employers for 2020

Subjects
Can-Fite BioPharma Ltd., Vice presidents (Organizations), Workplace diversity, Employers, Pharmaceutical industry, Textiles, Biological products industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) is proud to be recognized as one of Canada's Best Diversity Employers for the fourth [...]

Published
2020

22. Can-Fite Updates on Clinical Milestone for its Phase III Rheumatoid Arthritis Study with Piclidenoson; Drugs Combating Rheumatoid Arthritis are Currently Introduced for the Treatment of the Coronavirus

Subjects
Can-Fite BioPharma Ltd., Clinical trials, Rheumatoid factor, Pharmaceutical industry, Arthritis -- Drug therapy, Antiarthritic agents, Drugs, Liver diseases, Biological products industry, Liver, Biotechnology industries, Diseases, General interest, News, opinion and commentary
Abstract

PETACH TIKVA, Israel: Can-Fite BioPharma Ltd. has issued the following news release: -Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs [...]

Published
2020

23. Accidental T-cell Discovery Represents 'A New Frontier' in Cancer Treatment

Subjects
Merck KGaA, Novartis AG, Can-Fite BioPharma Ltd., Cancer treatment -- Research, Medical research, Biotechnology industries -- Research, Pharmaceutical industry -- Research, T cells -- Research, Biochemistry, Cancer research, Technology, Biotechnology, General interest, News, opinion and commentary
Abstract

LOS ANGELES: USA News Group has issued the following press release: USA News Group - While it has not yet been tested in patients, researchers say an accidental T-cell discovery [...]

Published
2020

24. Pre-clinical Studies Demonstrate CBD's Robust Anti-Cancer Effect Against Liver Cancer; Can-Fite and Univo Pharmaceuticals Expand Collaboration Agreement

Subjects
Can-Fite BioPharma Ltd., Clinical trials, Liver cancer, Cancer research, Pharmaceutical industry, Cancer cells, Cancer, Medical research, Biological products industry, Diseases, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite BioPharma Ltd. has issued the following news release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biopharmaceutical company with a pipeline of proprietary small molecule drugs that address [...]

Published
2020

25. CN Supportive of the Amendment to the Ministerial Order on Train Speed

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Cabinet officials, Technology, Railroads, Biological products industry, Investments, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) is supportive of the decision by Canada's Transport Minister to amend the Ministerial Order issued [...]

Published
2020

26. CN Forced to Shut Down Parts of Network Due to Blockades

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Biological products industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) announced that it will be forced to shut down significant parts of its Canadian network [...]

Published
2020

27. Can-Fite BioPharma Announces Pricing of $5 Million Public Offering

Subjects
Can-Fite BioPharma Ltd., Stock offerings, Pharmaceutical industry, Biological products industry, Fees, Securities offerings, Advertising executives, Drugs, Liver diseases, Legal fees, Liver, Biotechnology industries, Diseases, General interest, News, opinion and commentary
Abstract

PETACH TIKVA: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that [...]

Published
2020

28. CN Named One of Montreal's Top Employers

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Biological products industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) CN is pleased to be recognized as one of Montreal's Top Employers for 2020 by [...]

Published
2020

29. CN Strengthens its Commitment to Safety by Equipping its CNTL Fleet with ISAAC's Telemetry Solution

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Motor vehicle drivers, Biological products industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) is pleased to announce that CNTL, CN's road transportation subsidiary, has selected ISAAC's Instruments' telemetry [...]

Published
2020

30. Can-Fite BioPharma Ltd falls 11% premarket on planned $5Mequity offering

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Biological products industry, Advertising executives, General interest, News, opinion and commentary
Abstract

Can-Fite BioPharma Ltd. (NYSEMKT:CANF) decreases 11% premarket on light volume in response to its planned $5M offering of units Each Unit consisting of one American Depositary Share (ADS) and one [...]

Published
2020

31. CANF, CPAH among gainers in Friday's pre-market session

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Securities trading, Stock prices, Biological products industry, General interest, News, opinion and commentary
Abstract

Can-Fite BioPharma Ltd. CANF 1.11% shares rose 16.5% to $3.18 in pre-market trading CounterPath Corporation CPAH 6.81% climbed 12.5% to $2.97 in pre-market trading Mechel PAO MTL 5.77% gained 9% [...]

Published
2020

32. Can-Fite Announces Exercise of Warrants for Cash Proceeds of $2.4 Million

Subjects
United States. Securities and Exchange Commission, Can-Fite BioPharma Ltd., Liver cancer, Pharmaceutical industry, Advertising executives, Liver diseases, Biological products industry, Liver, Biotechnology industries, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite BioPharma Ltd. has issued the following news release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address [...]

Published
2020

33. News Flash:Can-Fite Announces Exercise of Warrants for Cash Proceeds of $2.4 Million

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Advertising executives, Liver diseases, Biological products industry, Liver, Biotechnology industries, General interest, News, opinion and commentary
Abstract

-Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced the agreement by [...]

Published
2020

34. Can-Fite CEO Issues Letter to Shareholders

Subjects
Can-Fite BioPharma Ltd., Stockholders, Liver cancer, Chief executive officers, Pharmaceutical industry, Liver diseases, Media executives, Biological products industry, Liver, General interest, News, opinion and commentary
Abstract

PETACH TIKVA, Israel: Can-Fite BioPharma Ltd. has issued the following news release: Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs [...]

Published
2020

35. New Data From Hadassah Medical Center Lab Show Can-Fite's Namodenoson Induces Weight Loss

Subjects
Can-Fite BioPharma Ltd., College faculty, Medical centers, Pharmaceutical industry, Liver, Weight loss, Liver diseases, Glucose, Biological products industry, Biotechnology industries, General interest, News, opinion and commentary
Abstract

PETACH TIKVA: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that [...]

Published
2020

36. CN: Network Performance Recovered

Subjects
Can-Fite BioPharma Ltd., Labor disputes, Pharmaceutical industry -- International economic relations, Biological products industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) announced today that less than a month after the end of the 8-day labour action, [...]

Published
2019

37. Teck and CN Announce Significant Rail Shipping Agreement

Subjects
Teck Resources Ltd., Can-Fite BioPharma Ltd., Mining industry -- International economic relations, Ports, Pharmaceutical industry -- International economic relations, Biological products industry, Investments, Infrastructure (Economics), General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) and Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) announced today a long-term rail [...]

Published
2019

38. CN Continues to Execute Recovery Plan

Subjects
Can-Fite BioPharma Ltd., Financial statements, Pharmaceutical industry -- International economic relations, Weather, Media executives, Biological products industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) today announced that its recovery plan is on track and that it is revising its [...]

Published
2019

39. CN and Conductors Reach Tentative Agreement

Subjects
Can-Fite BioPharma Ltd., Labor contracts, Pharmaceutical industry, Biological products industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) is announcing that a tentative agreement has been reached with our 3,200 CN conductors and [...]

Published
2019

40. CN meets U.S federal requirement to operate Positive Train Control on all required tracks ahead of schedule

Subjects
Can-Fite BioPharma Ltd., Vice presidents (Organizations), Chief operating officers, Pharmaceutical industry, Media executives, Biological products industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR)(NYSE: CNI) announced today that it has successfully met the federal requirement to operate Positive Train Control (PTC) [...]

Published
2019

41. Can-Fite BioPharma to Hold Investor Webinar and Q&A Session with CEO on November 25, 2019

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Biological products industry, Chief executive officers, Liver diseases, Web sites (World Wide Web), Liver, Biotechnology industries, General interest, News, opinion and commentary
Abstract

PETACH TIKVA, Israel: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE American: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that [...]

Published
2019

42. MEDIA INVITATION: The 15th edition of the CN Canadiens Alumni Challenge will be held on November 16, 2019

Subjects
Can-Fite BioPharma Ltd., Charities, Pharmaceutical industry, Biological products industry, Retirees, General interest, News, opinion and commentary, Montreal Canadiens
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) invites the media to attend the 15th edition of the CN Canadiens Alumni Challenge, which [...]

Published
2019

43. James Street Swing Bridge Reopening

Subjects
Can-Fite BioPharma Ltd., Vice presidents (Organizations), Pharmaceutical industry, Biological products industry, Bridges (Structures), General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) is pleased to announce that the repair work on the James Street Swing Bridge is [...]

Published
2019

44. Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients

Subjects
Can-Fite BioPharma Ltd., Cancer treatment -- Usage, Liver cancer -- Drug therapy -- Usage, Pharmaceutical industry -- Usage, Cancer patients -- Drug therapy -- Usage, Clinical trials, Biological products industry, General interest, News, opinion and commentary
Abstract

PETACH TIKVA: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that [...]

Published
2019

45. Can-Fite BioPharma Interview to Air on Bloomberg International on the RedChip Money Report

Subjects
Can-Fite BioPharma Ltd., Biological products industry, Liver diseases, Liver, Biotechnology industries, General interest, News, opinion and commentary
Abstract

PETACH TIKVA: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE American: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address [...]

Published
2019

46. Can-Fite Completes Patient Enrollment in Phase II NASH Study of Namodenoson

Subjects
Can-Fite BioPharma Ltd., Medical research, Liver, Fatty liver, Liver diseases, Biological products industry, General interest, News, opinion and commentary
Abstract

PETACH TIKVA, Israel: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs [...]

Published
2019

47. Can Fite Announces Publication of Namodenoson NASH Mechanism of Action in International Journal of Molecular Medicine

Subjects
Can-Fite BioPharma Ltd., Liver diseases, Pharmaceutical industry, Liver, Liver cancer, Drugs, Biological products industry, Biotechnology industries, General interest, News, opinion and commentary
Abstract

PETACH TIKVA, Israel: Can-Fite BioPharma Ltd. has issued the following press release: Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs [...]

Published
2019

48. CN Publishes 2019-2020 Winter Plan

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Biological products industry, Investments, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: As part of its commitment to delivering safely during winter, CN (TSX: CNR) (NYSE: CNI) is pleased to announce that, [...]

Published
2019

49. MEDIA AVAILABILITY CN Police officers available for media interviews during Rail Safety Week

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Police officers, Police departments, Trespass, Biological products industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: CN (TSX: CNR) (NYSE: CNI) is offering members of the media the opportunity to talk with uniformed police officers during [...]

Published
2019

50. Ghislain Houle CN executive vice president and chief financial officer, to address CIBC 18th Annual Eastern Institutional investor conference on September 25

Subjects
Can-Fite BioPharma Ltd., Pharmaceutical industry, Chief financial officers, Web sites (World Wide Web), Media executives, Biological products industry, General interest, News, opinion and commentary
Abstract

Israel: Can-Fite Biopharma Ltd has issued the following press release: Ghislain Houle, executive vice-president and chief financial officer of CN (TSX: CNR) (NYSE: CNI), will address the CIBC 18th Annual [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results